Identifying a single, targeted pharmacological agent to address this unified pathophysiology is an urgent unmet need
However, more independent research needs to be done on digestive enzymes to confirm that they have benefits, says Dr
ZEPBOUND **General Notes:**- All listed drugs are administered as once-weekly subcutaneous injections.- Off-label use for weight loss has been common for Ozempic and Mounjaro prior to the approval of Wegovy and Zepbound for obesity.- Dosages vary by patient needs and indication but typically start at lower doses and are titrated up.- Main risks under emerging research include potential severe vision complications (e.g., NAION) in addition to commonly known side effects
Results based on a January 2026 analysis of 14,203 Noom GLP-1Rx Program members who actively logged weight over a 40 week period
Katz, M.D., M.P.H., is the former director of Yale University Prevention Research Center, and a specialist in internal medicine, preventive medicine/public health, and lifestyle medicine, with particular expertise in nutrition
In pregnancy, selenium deficiency has been associated with an increased risk of complications like preeclampsia and miscarriage
